BrainStorm Cell Therapeutics
BCLI
#10385
Rank
NZ$10.95 M
Marketcap
NZ$0.99
Share price
-4.76%
Change (1 day)
-69.65%
Change (1 year)

Earnings for BrainStorm Cell Therapeutics (BCLI)

Earnings in 2025 (TTM): -NZ$18.73 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -NZ$19.23 Million, an increase over its 2023 earnings that were of -NZ$28.44 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BrainStorm Cell Therapeutics from 2003 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$18.73 Million-2.63%
2024 -NZ$19.23 Million-32.39%
2023 -NZ$28.44 Million-29.18%
2022 -NZ$40.16 Million-0.74%
2021 -NZ$40.46 Million-23.12%
2020 -NZ$52.62 Million36.8%
2019 -NZ$38.47 Million66.71%
2018 -NZ$23.08 Million181.66%
2017 -NZ$8.2 Million-0.6%
2016 -NZ$8.25 Million-41.31%
2015 -NZ$14.05 Million-8.22%
2014 -NZ$15.3 Million89.74%
2013 -NZ$8.07 Million42.27%
2012 -NZ$5.67 Million-12.45%
2011 -NZ$6.48 Million63.04%
2010 -NZ$3.97 Million35.52%
2009 -NZ$2.93 Million-48.99%
2008 -NZ$5.75 Million-44.39%
2007 -NZ$10.33 Million
2005 -NZ$5.35 Million-91.44%
2004 -NZ$62.5 Million94007.62%
2003 -NZ$0.07 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Biogen
BIIB
NZ$3.14 B-17,654.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$16.35 B-91,248.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
-NZ$1.31 Billion 7,189.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-NZ$1.25 Billion 6,832.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
NZ$34.17 M-290.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
-NZ$0.43 Billion 2,255.61%๐Ÿ‡บ๐Ÿ‡ธ USA